Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

1.4%

6 terminated/withdrawn out of 426 trials

Success Rate

93.0%

+6.5% vs industry average

Late-Stage Pipeline

16%

69 trials in Phase 3/4

Results Transparency

1%

1 of 80 completed trials have results

Key Signals

92 recruiting1 with results4 withdrawn

Enrollment Performance

Analytics

N/A
137(47.2%)
Phase 2
73(25.2%)
Phase 3
37(12.8%)
Phase 4
32(11.0%)
Phase 1
10(3.4%)
Early Phase 1
1(0.3%)
290Total
N/A(137)
Phase 2(73)
Phase 3(37)
Phase 4(32)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (426)

Showing 20 of 426 trials
NCT07644247Phase 4Not Yet Recruiting

STudy of Aspirin Removal in Patients Supported by the Fully Magnetically Levitated CH-VAD Pump

Role: collaborator

NCT06676631Phase 1Recruiting

NK010 or NK042 in Combination With Rituximab for Refractory Systemic Lupus Erythematosus/Lupus Nephritis

Role: lead

NCT07645846Phase 2Not Yet Recruiting

Neoadjuvant Docetaxel, Cisplatin, and Dual Immunotherapy for Sinonasal Carcinoma

Role: collaborator

NCT07620626Recruiting

Real-World Study of Woven EndoBridge for Intracranial Aneurysm Treatment

Role: collaborator

NCT07441382Not ApplicableRecruiting

Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation

Role: lead

NCT06711016Not ApplicableRecruiting

Target-directed Management of Cerebral Oxygenation in Patients After Receiving ECPR

Role: collaborator

NCT07604688Recruiting

Multicenter Registry Study of Patients With Intracranial Dural Arteriovenous Fistulas in China

Role: collaborator

NCT07626736Not ApplicableRecruiting

Evaluating the Efficacy and Safety of AI Localization Models in Multidisciplinary Team Care for NSCLC

Role: collaborator

NCT07623213Not ApplicableNot Yet Recruiting

AI-Guided Intensified Follow-up After Surgery for Acute Type A Aortic Dissection

Role: collaborator

NCT07617675Phase 4Not Yet Recruiting

rhBNP for Prevention of Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI)

Role: collaborator

NCT07176182Phase 2Recruiting

Clinical Trial of Neoadjuvant mFOLFOX Plus Alvenor for LARC Patients With High YWHAB Expression

Role: collaborator

NCT07604805Not ApplicableRecruiting

Efficacy and Safety of Qishen Yiqi Dropping Pills in Patients With Severe Pulmonary Hypertension

Role: lead

NCT06061627Not ApplicableRecruiting

A Randomized Controlled Trial of LOT-CRT Versus conventionaL BiVP in Heart Failure Patients With NICD

Role: collaborator

NCT07514611Not ApplicableRecruiting

Weight Loss Via Intelligent Guidance in Patients With Coronary Heart Disease and Obesity: a Randomized Clinical Trial

Role: lead

NCT07577050Phase 2Not Yet Recruiting

A Phase II Study of NB001 for Acute Migraine Treatment

Role: collaborator

NCT03385902Not ApplicableCompleted

Assessment of Dialysis Initiation by a Fuzzy Mathematics Equation

Role: collaborator

NCT05453721Not ApplicableCompleted

Effect and Long-Term Outcomes of Indocyanine Green Fluorescence Imaging Method Versus Modified Inflation-Deflation Method in Identification of Intersegmental Plane（IMPLANE-0529）

Role: collaborator

NCT05957510Phase 2Recruiting

Safety and Efficacy Evaluation of Serplulimab Plus Chemo in SCLC Transformed From EGFR-mutated NSCLC After Treatment

Role: collaborator

NCT04944914Phase 3Recruiting

Camrelizumab Plus Stereotactic Body Radiotherapy vs Camrelizumab Alone For Oligometastatic Nasopharyngeal Carcinoma

Role: collaborator

NCT07130968Enrolling By Invitation

Real-World Cohort Study of Cardiopulmonary Function in Chinese Patients With Cardiovascular Disease: CPET Evaluation and Five-Year Prognostic Follow-Up Based on a Multicenter Structured Data Platform

Role: lead